- Home
- RRR vs IRTC Comparison
RRR vs IRTC Comparison
Compare RRR & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRR
- IRTC
- Stock Information
- Founded
- RRR 1976
- IRTC 2006
- Country
- RRR United States
- IRTC United States
- Employees
- RRR N/A
- IRTC N/A
- Industry
- RRR Hotels/Resorts
- IRTC Medical/Dental Instruments
- Sector
- RRR Consumer Discretionary
- IRTC Health Care
- Exchange
- RRR Nasdaq
- IRTC Nasdaq
- Market Cap
- RRR 3.0B
- IRTC 3.1B
- IPO Year
- RRR 2016
- IRTC 2016
- Fundamental
- Price
- RRR $40.70
- IRTC $100.96
- Analyst Decision
- RRR Buy
- IRTC Strong Buy
- Analyst Count
- RRR 14
- IRTC 10
- Target Price
- RRR $56.14
- IRTC $120.20
- AVG Volume (30 Days)
- RRR 737.2K
- IRTC 365.8K
- Earning Date
- RRR 05-01-2025
- IRTC 05-01-2025
- Dividend Yield
- RRR 2.45%
- IRTC N/A
- EPS Growth
- RRR N/A
- IRTC N/A
- EPS
- RRR 2.53
- IRTC N/A
- Revenue
- RRR $1,939,011,000.00
- IRTC $591,839,000.00
- Revenue This Year
- RRR $2.22
- IRTC $17.46
- Revenue Next Year
- RRR $3.68
- IRTC $16.93
- P/E Ratio
- RRR $16.07
- IRTC N/A
- Revenue Growth
- RRR 12.47
- IRTC 20.13
- 52 Week Low
- RRR $35.09
- IRTC $55.92
- 52 Week High
- RRR $61.73
- IRTC $128.52
- Technical
- Relative Strength Index (RSI)
- RRR 43.15
- IRTC 46.56
- Support Level
- RRR $40.18
- IRTC $98.41
- Resistance Level
- RRR $41.84
- IRTC $104.12
- Average True Range (ATR)
- RRR 2.34
- IRTC 6.10
- MACD
- RRR 0.24
- IRTC -0.15
- Stochastic Oscillator
- RRR 65.46
- IRTC 50.18
Stock Price Comparison Chart: RRR vs IRTC
About RRR Red Rock Resorts Inc.
Red Rock Resorts Inc along with its subsidiary is a gaming, development, and management company. The company mainly develops strategically located casino and entertainment properties. It generates a majority of its revenue from Casino.
About IRTC iRhythm Technologies Inc.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.